Virios Therapeutics, Inc.·4

Dec 14, 6:31 PM ET

Grosswald Ralph 4

4 · Virios Therapeutics, Inc. · Filed Dec 14, 2022

Insider Transaction Report

Form 4
Period: 2022-12-12
Grosswald Ralph
SVP OF OPERATIONS
Transactions
  • Award

    Stock Option (right to buy)

    2022-12-12+80,00080,000 total
    Exercise: $0.28Exp: 2032-12-12Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.

Documents

1 file
  • 4
    form4-12142022_111254.xmlPrimary